University of Stellenbosch
107
15
24
56
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
3.7%
4 terminated/withdrawn out of 107 trials
93.3%
+6.8% vs industry average
14%
15 trials in Phase 3/4
14%
8 of 56 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (107)
Tuberculosis Clinical Trials Consortium Study 35
Role: collaborator
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
Role: collaborator
Strengthening Informed Consent for Authentic Participation in Perinatal HIV Research
Role: collaborator
The LalelaLung Study: Digital Stethoscope Clinical Evaluation
Role: collaborator
Testing Health Workers At Risk to Advance Our Understanding of TB Infection
Role: collaborator
Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.
Role: collaborator
Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides
Role: collaborator
Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life
Role: collaborator
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
Role: collaborator
Intervention Development for Syndemics Among PWH in SA
Role: collaborator
Outpatient Pediatric Pulse Oximeters in Africa
Role: collaborator
Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis
Role: collaborator
Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19
Role: collaborator
Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis
Role: lead
Rapid Research in Diagnostics Development for TB Network
Role: collaborator
Cough Audio Classification as a TB Triage Test
Role: lead
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
Role: collaborator
Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut Microbiota
Role: lead
Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)
Role: collaborator
Auditory Research in Children Living With HIV Exposure-uninfected (ARCHIVE)
Role: collaborator